News

Pharmabiz1h
ProFound Therapeutics enters multi-year strategic collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease
ProFound Therapeutics enters multi-year strategic collaboration with Novartis to discover and develop novel therapeutics for cardiovascular disease: Cambridge, Massachusetts Frida ...
Pharmabiz2h
Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis
Galderma begins 2 new clinical trials to investigate efficacy and safety of nemolizumab to treat patients with systemic sclerosis: Zug, Switzerland Friday, June 27, 2025, 13:00 Hr ...
Pharmabiz2h
Telangana DCA sets new precedent with arrest of two wholesalers for selling counterfeit drugs
Telangana DCA sets new precedent with arrest of two wholesalers for selling counterfeit drugs: Peethaambaran Kunnathoor, Chennai Friday, June 27, 2025, 13:10 Hrs [IST] For the fir ...
Pharmabiz4h
Recordati signs licensing agreement with Amarin to commercialize cardiovascular medicine, Vazkepa in Europe
Recordati signs licensing agreement with Amarin to commercialize cardiovascular medicine, Vazkepa in Europe: Milan, Italy Friday, June 27, 2025, 11:00 Hrs [IST] Recordati, an inte ...
Pharmabiz3h
China NMPA accepts CARsgen Therapeutics’ NDA for satri-cel to treat Claudin18.2-positive advanced G/GEJA
China NMPA accepts CARsgen Therapeutics’ NDA for satri-cel to treat Claudin18.2-positive advanced G/GEJA: Shanghai, China Friday, June 27, 2025, 12:00 Hrs [IST] CARsgen Therapeu ...
Pharmabiz5h
Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors
Pfizer announces positive results from phase 3 BASIS study of Hympavzi in haemophilia A or B with inhibitors: New York Friday, June 27, 2025, 10:00 Hrs [IST] Pfizer Inc. announced ...
Pharmabiz7h
Gap between domestic GMP & GMP required for intl compliance is huge: Dr Amaresh Tumbagi
Gap between domestic GMP & GMP required for intl compliance is huge: Dr Amaresh Tumbagi: Nandita Vijayasimha, Bengaluru Friday, June 27, 2025, 08:00 Hrs [IST] Drug regulators have ...
Pharmabiz7h
10th edition of Pharmac South expands to 175+ stalls, expected to attract 15,000 visitors
Pharmac South expands to 175+ stalls, expected to attract 15,000 visitors: Peethaambaran Kunnathoor, Chennai Friday, June 27, 2025, 08:00 Hrs [IST] The upcoming 10 ...
Pharmabiz7h
DCC agrees with DTAB proposal to fix QR codes on vaccines, antimicrobials, anticancer & NDPS drugs
DCC agrees with DTAB proposal to fix QR codes on vaccines, antimicrobials, anticancer & NDPS drugs: Gireesh Babu, New Delhi Friday, June 27, 2025, 08:00 Hrs [IST] The Drugs Consul ...
Pharmabiz7h
NABH announces initiation process for its 3-day Assessors’ Training Programme for entry level hospitals
NABH announces initiation process for its 3-day Assessors’ Training Programme for entry level hospitals: Shardul Nautiyal, Mumbai Friday, June 27, 2025, 08:00 Hrs [IST] The Nati ...
Pharmabiz7h
Karnataka govt on a 3-year mission for advanced healthcare access
Karnataka govt on a 3-year mission for advanced healthcare access: Nandita Vijayasimha, Bengaluru Friday, June 27, 2025, 08:00 Hrs [IST] The Karnataka government is ramping up eff ...
Pharmabiz21h
Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation
Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...